Skip to content
Altius – Lifestyle
Author:
PridCor Therapeutics, LLC
PridCor Therapeutics Announces First Patient Enrolled in Phase 2 SHIELD Study of a Combination Antiviral Regimen for Long COVID
November 10, 2026
PridCor Therapeutics Advances Phase 2 SHIELD Study of a Combination Antiviral Regimen for Long COVID Toward Enrollment
September 24, 2026